Consolidation With Hyper-CVAD or VP Plus Dasatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Randomized Controlled Trial. // Clinical Lymphoma, Myeloma & Leukemia. – URL: https://www.sciencedirect.com/science/article/pii/S2152265026040073?dgcid=rss_sd_all
Consolidation With Hyper-CVAD or VP Plus Dasatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Randomized Controlled Trial. Clinical Lymphoma, Myeloma & Leukemia. https://www.sciencedirect.com/science/article/pii/S2152265026040073?dgcid=rss_sd_all
“Consolidation With Hyper-CVAD or VP Plus Dasatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Randomized Controlled Trial.” Clinical Lymphoma, Myeloma & Leukemia.
@article{article41264,
title = {Consolidation With Hyper-CVAD or VP Plus Dasatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Randomized Controlled Trial},
journal = {Clinical Lymphoma, Myeloma \& Leukemia},
url = {https://www.sciencedirect.com/science/article/pii/S2152265026040073?dgcid=rss_sd_all}
}